Caxton Associates (New York)’s Myovant Sciences Ltd. MYOV Stock Holding History

Caxton Associates (New York)’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,977	Closed	-$215K	–	679
2022 Q4	$215K	Buy	+7,977	New	+$210K	0.01%	372

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caxton Associates (New York)'s MYOV Position: Q1 2023 in Review

Caxton Associates (New York) sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 7,977 shares — an estimated $215K sold.

Caxton Associates (New York) first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $215K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Caxton Associates (New York) reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Caxton Associates (New York) sold 7,977 Myovant Sciences Ltd. shares in Q1 2023, an estimated $215K.
Caxton Associates (New York) first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
Caxton Associates (New York)'s Myovant Sciences Ltd. position peaked at $215K in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.